Atlas Trials

Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

Clinical trial NCT03507088 · COMPLETED

Trial details

NCT number
NCT03507088
Sponsor
Zhimin Shao
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2015-09-01
Primary completion
2018-07-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.